Literature DB >> 12621686

[Acute therapy of ischemic stroke].

Wilfried Lang1, Wolfgang Lalouschek.   

Abstract

Thrombolysis was used in 3.7% of stroke patients who were admitted to the Neurological Departments of Vienna. High doses of heparin were associated with an increased risk of secondary symptomatic hemorrhage (OR 10.3; 95% CI 2.4-43.2). But none of the patients with TIA or minor stroke who received high dosages of heparin suffered from secondary symptomatic hemorrhage. Spontaneous or therapeutically induced decrease of the diastolic blood pressure by more than 20 mmHg was associated with a three-fold risk of an unfortunate functional outcome. Complications following stroke are frequent and most likely to occur within the first 5 days. Pneumonia was found to be an independent risk factor for an unfortunate functional outcome after three months. A main field of activity of stroke units should be to prevent or to early recognize and treat complications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12621686     DOI: 10.1046/j.1563-258x.2003.02109.x

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  23 in total

1.  Effect of intravenous nimodipine on blood pressure and outcome after acute stroke.

Authors:  N Ahmed; P Näsman; N G Wahlgren
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

2.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

3.  Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome.

Authors:  T Brandt; R von Kummer; M Müller-Küppers; W Hacke
Journal:  Stroke       Date:  1996-05       Impact factor: 7.914

Review 4.  Overview of Cochrane thrombolysis meta-analysis.

Authors:  J M Wardlaw
Journal:  Neurology       Date:  2001       Impact factor: 9.910

5.  Low-molecular-weight heparins and heparinoids in acute ischemic stroke : a meta-analysis of randomized controlled trials.

Authors:  P M Bath; R Iddenden; F J Bath
Journal:  Stroke       Date:  2000-07       Impact factor: 7.914

6.  A pilot study of drug-induced hypertension for treatment of acute stroke.

Authors:  G Rordorf; W J Koroshetz; M A Ezzeddine; A Z Segal; F S Buonanno
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

7.  Alternative strategies for stroke care: a prospective randomised controlled trial.

Authors:  L Kalra; A Evans; I Perez; M Knapp; N Donaldson; C G Swift
Journal:  Lancet       Date:  2000-09-09       Impact factor: 79.321

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.

Authors: 
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

10.  Gastrointestinal hemorrhage after acute stroke.

Authors:  R J Davenport; M S Dennis; C P Warlow
Journal:  Stroke       Date:  1996-03       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.